Consensus ProKidney Corp.

Equities

PROK

KYG7S53R1049

Real-time Estimate Cboe BZX Other stock markets 03:06:40 2024-05-21 pm EDT			5-day change	1st Jan Change
3.645 ^USD	-7.02%		+27.27%	+120.22%

May. 10	ProKidney Q1 Loss Unchanged From Year Earlier	MT
May. 10	ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on ProKidney Corp.

Price target over the last 5 years

History of analyst recommendation changes

f06b6612a9f3343.Tvw9AqtG5fAlOYY4PYX_tzLEUPFFbPcYQv4yIXHV2PQ.FJ1JdeEcsJ9WbPxObLWK8360BLUUGY1VdrF_ZRSNnqF8tA9z_TKwoG9esg~36a1d7b9a2cdf70e381c5a228ef12f8d

Analyst Recommendations on ProKidney Corp.

BofA Securities Downgrades ProKidney to Neutral From Buy, Cuts Price Target to $2 From $8	Jan. 02	MT
BTIG Initiates ProKidney With Buy Rating, $16 Price Target	23-07-25	MT
Jefferies Initiates ProKidney With Buy Rating, Price Target is $15	22-12-21	MT
Morgan Stanley Starts ProKidney at Equalweight With $13 Price Target	22-11-10	MT
UBS Initiates Coverage on ProKidney With Buy Rating, $18 Price Target	22-10-18	MT
Citigroup Starts ProKidney at Buy With $16 Price Target	22-10-14	MT
BofA Securities Starts ProKidney at Buy With $14 Price Target	22-09-23	MT
Evercore ISI Initiates Coverage on ProKidney With Outperform Rating	22-09-02	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

3.88 USD

Average target price

4.4 USD

Spread / Average Target

+13.40%

High Price Target

6 USD

Spread / Highest target

+54.64%

Low Price Target

3 USD

Spread / Lowest Target

-22.68%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ProKidney Corp.

BofA Securities
BTIG
Jefferies & Co.
Morgan Stanley
UBS
Citigroup
Evercore ISI

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar